Archive for August 27th, 2026

๐“๐ก๐ž ๐ก๐ข๐ ๐ก๐ž๐ฌ๐ญ ๐œ๐ฅ๐ข๐ง๐ข๐œ๐š๐ฅ ๐ญ๐ซ๐ข๐š๐ฅ ๐Ÿ๐š๐ข๐ฅ๐ฎ๐ซ๐ž ๐ซ๐š๐ญ๐ž ๐Ÿ๐จ๐ซ ๐š๐ง๐ฒ ๐๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ข๐ง ๐ฆ๐จ๐๐ž๐ซ๐ง ๐ฆ๐ž๐๐ข๐œ๐ข๐ง๐ž: ๐‡๐จ๐ฐ ๐›๐จ๐ญ๐ก ๐š๐ฆ๐ฒ๐ฅ๐จ๐ข๐- ๐š๐ง๐ ๐ง๐จ๐ง-๐š๐ฆ๐ฒ๐ฅ๐จ๐ข๐-๐ญ๐š๐ซ๐ ๐ž๐ญ๐ข๐ง๐  ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ข๐ž๐ฌ ๐Ÿ๐š๐ข๐ฅ๐ž๐ ๐ญ๐จ ๐š๐ฅ๐ญ๐ž๐ซ ๐๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐œ๐จ๐ฎ๐ซ๐ฌ๐ž ๐ข๐ง ๐€๐ฅ๐ณ๐ก๐ž๐ข๐ฆ๐ž๐ซ’๐ฌ ๐๐ข๐ฌ๐ž๐š๐ฌ๐ž

Posted by Michael A. S. Guth on August 27th, 2026

The post-2022 period revealed that genuinely novel non-amyloid mechanismsโ€”TREM2 agonism, GLP-1 receptor stimulation, filamin A modulation, and progranulin/sortilin restorationโ€”also failed to produce clinical benefit at scale despite confirmed target engagement.

Posted in Aging Adults, Neuroplasticity, Pharma and Medical Device, Regulatory Medical Writing No Comments »
Read More »